Clinical Trial Update: Exploratory Study to Evaluate the Use of the RxSight Light Adjustable Lens (LAL) and the Light Delivery Device (LDD) to Improve Visual Outcomes

View source ↗

Summary

Exploratory study evaluating RxSight Light Adjustable Lens and light delivery device to improve visual outcomes in aphakia and cataract patients; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphakia
• Cataract

Drugs mentioned

• Light Adjustable Lens (intraocular lens)

Snippet

Sponsor: RxSight, Inc. | Conditions: Aphakia, Cataract | Status: COMPLETED | Results posted: 2021-09-22